isabelobrien, Author at European Medical Journal - Page 50 of 68

Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship

How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.

Pharma's next move in the online jungle

What lies in wait for pharma in the social media jungle?

Bolstering data ownership with blockchain

Blockchain allow patients to own their data and better protects their personal information. How could it change the data landscape in pharma?

Pharma in India

India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?

Are MSLs ready for the spotlight?

How can the industry empower MSLs as they do sales reps?

A pandemic response in 100 days

This infographic looks at the mission to make an effective vaccine against any virus in just 100 days and explores the diseases that are re-emerging that could be combatted with an expedited approach.

Access win for HIV patients in sub-Saharan Africa

The injectable HIV treatment cabotegravir is set to become more widely available in sub-Saharan Africa following a new licensing agreement.

The Sunshine Rule: 5 years on

The Sunshine Rule swept away the clouds that cast shade over the pharmaceutical industry’s interactions with its customers, but what has been its impact five years on?

Sanofi lights ‘Beacon of Hope’ in race for greater diversity

Sanofi has joined the ‘Beacon of Hope’ programme – a Novartis initiative seeking to address racial inequality in clinical trials, health and education and to create greater diversity across R&D structures.

Sanofi Genzyme’s Bill Sibold on preventing future health inequities

Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.